Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

RNA-seq

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...

Ribosome Profiling

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals heterogeneity in OXPHOS and EMT gradients.

Nature communications·2026

Same author

scDock: streamlining drug discovery targeting cell-cell communication via scRNA-seq analysis and molecular docking.

Bioinformatics (Oxford, England)·2026

Same author

Reactive oxygen species driven immune inflammation in systemic sclerosis: mechanisms and emerging therapeutics.

Drug discovery today·2026

Same author

Mass spectrometry-based human spatial omics: fundamentals, innovations, and applications.

Journal of biomedical science·2026

Same author

Transcriptional dynamics of CD8<sup>+</sup> T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution.

Molecular cancer·2025

Same author

Correction: Dynamic expression of cathepsin L in the black soldier fly (Hermetia illucens) gut during Escherichia coli challenge.

PloS one·2025

Search research articles

Related Experiment Video

Updated: Aug 16, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

scDrug: From single-cell RNA-seq to drug response prediction.

Chiao-Yu Hsieh¹, Jian-Hung Wen^1,2, Shih-Ming Lin^1,3,4

¹Taiwan AI Labs, Taipei 10351, Taiwan.

Computational and Structural Biotechnology Journal

|December 22, 2022

Summary

scDrug is a new bioinformatics workflow for analyzing single-cell RNA sequencing data. It helps identify tumor cell subpopulations and predict drug responses, aiding drug discovery and repurposing.

Keywords:

Bioinformatics Drug repositioning Single-cell RNA-seq Tumor cell subpopulations

More Related Videos

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

Published on: November 11, 2014

Related Experiment Videos

Last Updated: Aug 16, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis

Published on: November 11, 2014

Area of Science:

Genomics
Bioinformatics
Cancer Research

Background:

Single-cell RNA sequencing (scRNA-seq) provides high-resolution transcriptome data for thousands of cells.
scRNA-seq is crucial for understanding the tumor microenvironment and its clinical implications.
Existing methods lack an integrated approach from scRNA-seq analysis to drug discovery.

Purpose of the Study:

To present scDrug, an integrated bioinformatics workflow for scRNA-seq data analysis.
To facilitate the identification of tumor cell subpopulations and predict drug responses.
To streamline the drug discovery and repurposing process using scRNA-seq data.

Main Methods:

scDrug employs a one-step pipeline for cell clustering of scRNA-seq data.
The workflow includes modules for scRNA-seq analysis, functional annotation, and drug response prediction.
Two distinct methods are incorporated for predicting drug treatments.

Main Results:

scDrug enables efficient identification of tumor cell subpopulations.
The workflow accurately predicts drug responses based on scRNA-seq data.
scDrug facilitates exploration of scRNA-seq data for drug repurposing.

Conclusions:

scDrug offers a comprehensive solution for scRNA-seq data analysis in cancer research.
The tool simplifies and accelerates the drug discovery pipeline.
scDrug is freely available, promoting wider accessibility and application.